• Acetoacetic Acid Sodium Salt: Assay Workflows

  2026-08-27

  Build reproducible ketone-body experiments with fresh sodium acetoacetate stocks, matched controls, and time-resolved readouts. This guide connects practical handling of Acetoacetic acid sodium salt with energy metabolism research, diabetes models, and analytical lessons from a deuterium-labeling study.

• T7 RNA Polymerase for Mechanism-Driven RNA Assays

  2026-08-27

  T7 RNA Polymerase enables defined RNA production for mechanistic gene-regulation studies. Learn how to use promoter-specific transcription to design stronger assays around the HEY2–mitochondrial respiration findings.

• Thrombin A1057: Reliable Cell Assay Workflows

  2026-08-26

  This scenario-based guide explains how Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens] (SKU A1057) can improve reagent definition, control design, and interpretation in cell viability, proliferation, and cytotoxicity studies. It connects product specifications with practical assay safeguards while distinguishing parent-thrombin biology from fragment-specific validation.

• Degarelix Acetate: From Binding to Translation

  2026-08-26

  A mechanistic and strategic guide to using Degarelix acetate as a GnRH receptor antagonist, connecting receptor pharmacology, stereochemistry, assay design, prostate cancer research, and translational decision-making.

• Lipidated Nanophotosensitizers Disable Tumor EVs

  2026-08-25

  This Nature Cancer study introduces palmitic-acid-displayed nanoparticles that distribute within tumor cells and tumor extracellular vesicles, enabling simultaneous photodynamic treatment of primary tumors and disruption of prometastatic vesicle communication. The work provides a selective, spatially coordinated strategy for addressing tumor growth and metastasis rather than treating these processes as independent endpoints.

• HyperPFU™ high-fidelity DNA polymerase: PCR Guide

  2026-08-25

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate amplification of long, GC-rich, or otherwise difficult DNA templates, particularly when blunt-ended products are acceptable. It should not be selected for workflows that require 3′-A overhangs or direct sticky-end generation without an additional end-processing step.

• Berberine hydrochloride: Gut–Bone Research Workflows

  2026-08-24

  Berberine hydrochloride enables integrated gut–bone, metabolic, and cell-death studies through controlled exposure, microbiome profiling, immune phenotyping, and organoid validation. This practical guide translates a 2026 tuft-cell study into reproducible workflows while addressing solubility, vehicle effects, and cross-model interpretation.

• PYR-41 E1 Inhibition: Reliable Cell Assays

  2026-08-24

  This scenario-driven guide shows how PYR-41, inhibitor of Ubiquitin-Activating Enzyme E1 (SKU B1492), can help researchers interpret viability, proliferation, cytotoxicity, and inflammatory signaling assays. It emphasizes solvent controls, dose-resolved designs, protein-stability readouts, and the limitations of translating E1 inhibition across models.

• Live-Dead Bacterial Staining Kit for Nanomaterials

  2026-08-23

  The Live-Dead Bacterial Staining Kit provides a membrane-based bacterial viability assay for testing antibacterial nanomaterials. This article explains how to interpret NucGreen and EthD-III signals mechanistically, using Fe3O4@ZIF-8 research as a case study while addressing assay limitations.

• Sulfo-NHS-SS-Biotin: Cleavable Surface Labeling

  2026-08-22

  Sulfo-NHS-SS-Biotin is a water-compatible, amine-reactive reagent for reversible protein labeling and surface-protein workflows. Its sulfo-NHS ester targets primary amines, while its disulfide spacer supports reduction-based label removal and avidin/streptavidin affinity chromatography.

• Cefiderocol Against Resistant European Non-Fermenters

  2026-08-22

  This reference study provides a large, direct in vitro comparison of cefiderocol with recent β-lactam/β-lactamase inhibitor combinations against European Pseudomonas aeruginosa and Acinetobacter spp., including meropenem-resistant isolates. Its findings support early, parallel susceptibility testing while also linking cefiderocol resistance to acquired β-lactamases and changes involving siderophore-iron transport components.

• Exo1 and the Next Logic of Membrane-Traffic Biology

  2026-08-21

  Exo1 offers an acute, mechanistically distinct way to interrogate Golgi–ER traffic, ARF1 behavior, and exocytosis. This thought-leadership perspective connects that tool to tumor extracellular vesicle research while distinguishing mechanistic validation from therapeutic claims.

• α-Linolenic Acid Research Workflows

  2026-08-20

  Build reproducible ALA experiments for lipid flux, cardiovascular signaling, inflammation, and cancer models with practical dosing and handling guidance. The workflow also shows how findings from an arachidonic acid vaccination study can inform—but not substitute for—careful α-Linolenic Acid immune-assay design.

• Cytochalasin D: Actin Control for Translational Research

  2026-08-20

  Cytochalasin D is more than a cytoskeletal perturbagen: it is a mechanistic tool for testing how actin dynamics influence cell-cycle control, cancer phenotypes, viral processes, and nanoparticle uptake. This article connects its established biology with translational strategy for researchers developing advanced cellular and ocular drug-delivery models.

• G-Quadruplexes Modulate TDP-43 Aggregation and Toxicity

  2026-08-19

  Oldani et al. show that RNA G-quadruplexes directly influence TDP-43 aggregation, intracellular distribution, and toxicity across biophysical and cellular models. The findings identify G-quadruplex populations as potential regulators of protein-misfolding stress, while also defining important limits for translating RNA-focused observations into therapeutic strategies.

8117 records 1/542 page Next 12345 下5页 Last page